Our amlodipine besylate tablet has been granted registration, with commercial supply beginning next quarter through appointed distributors.
Registration has been granted for Cardiplex 5 mg film-coated tablets following review of the manufacturing, analytical and stability sections of the dossier.
Commercial batches will reach appointed distributors next quarter in 2 x 10s blister packs. Institutional pack sizes can be arranged on request.
Full prescribing information is supplied with each pack. Medical queries can be directed to our medical affairs desk through the contact form.
More updates
Open to registered healthcare professionals, the session covers stewardship principles, resistance patterns and practical prescribing decisions.
Read more →We will be exhibiting alongside our distribution partners, with the formulation development team on hand to discuss contract manufacturing.
Read more →The new suite adds high-shear granulation and fluid bed drying capacity, lifting solid dosage output while keeping every batch under…
Read more →Q&A
Cannot find your answer? Ask the assistant in the corner of the screen, or write to us directly.
We post product launches, regulatory approvals, facility milestones and event participation as they happen — typically two to four updates a month.
Continuing medical education sessions are open to registered healthcare professionals. Registration details are published with each event listing.
Yes. We attend regional pharmaceutical exhibitions and distributor conferences. Upcoming appearances are listed here with stand numbers once confirmed.
Journalists may quote our published releases with attribution. For logos, images or interview requests, contact us and we will send the media pack.
Send us your product list, market and volumes. Our business development team replies within one working day.
